- Home
- PSTV vs TLPH Comparison
PSTV vs TLPH Comparison
Compare PSTV & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- TLPH
- Stock Information
- Founded
- PSTV 1996
- TLPH 2005
- Country
- PSTV United States
- TLPH United States
- Employees
- PSTV N/A
- TLPH N/A
- Industry
- PSTV Medical/Dental Instruments
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- PSTV Health Care
- TLPH Health Care
- Exchange
- PSTV Nasdaq
- TLPH Nasdaq
- Market Cap
- PSTV 10.4M
- TLPH 10.6M
- IPO Year
- PSTV N/A
- TLPH 2011
- Fundamental
- Price
- PSTV $0.18
- TLPH $0.44
- Analyst Decision
- PSTV Strong Buy
- TLPH Strong Buy
- Analyst Count
- PSTV 3
- TLPH 1
- Target Price
- PSTV $13.00
- TLPH $6.00
- AVG Volume (30 Days)
- PSTV 13.6M
- TLPH 31.7K
- Earning Date
- PSTV 08-13-2025
- TLPH 08-13-2025
- Dividend Yield
- PSTV N/A
- TLPH N/A
- EPS Growth
- PSTV N/A
- TLPH N/A
- EPS
- PSTV N/A
- TLPH N/A
- Revenue
- PSTV $5,206,000.00
- TLPH $27,000.00
- Revenue This Year
- PSTV $13.26
- TLPH N/A
- Revenue Next Year
- PSTV $8.84
- TLPH $14,533.26
- P/E Ratio
- PSTV N/A
- TLPH N/A
- Revenue Growth
- PSTV N/A
- TLPH N/A
- 52 Week Low
- PSTV $0.16
- TLPH $0.44
- 52 Week High
- PSTV $2.31
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- PSTV 29.61
- TLPH 31.91
- Support Level
- PSTV $0.16
- TLPH $0.45
- Resistance Level
- PSTV $0.36
- TLPH $0.52
- Average True Range (ATR)
- PSTV 0.04
- TLPH 0.03
- MACD
- PSTV -0.00
- TLPH -0.00
- Stochastic Oscillator
- PSTV 8.38
- TLPH 0.00
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.